Resources Contact Us Home
Recombinant toxin fragments

Image Number 4 for United States Patent #8017134.

A single polypeptide is provided which comprises first and second domains. The first domain enables the polypeptide to cleave one or more vesicle or plasma-membrane associated proteins essential to exocytosis, and the second domain enables the polypeptide to be translocated into a target cell or increases the solubility of the polypeptide, or both. The polypeptide thus combines useful properties of a clostridial toxin, such as a botulinum or tetanus toxin, without the toxicity associated with the natural molecule. The polypeptide can also contain a third domain that targets it to a specific cell, rendering the polypeptide useful in inhibition of exocytosis in target cells. Fusion proteins comprising the polypeptide, nucleic acids encoding the polypeptide and methods of making the polypeptide are also provided. Controlled activation of the polypeptide is possible and the polypeptide can be incorporated into vaccines and toxin assays.

  Recently Added Patents
Analog to digital converter with increased sub-range resolution
Thermoplastic fluoropolymer composition
Semiconductor unit having a power semiconductor and semiconductor apparatus using the same
Surface-emitting laser light source using two-dimensional photonic crystal
Wristband with detachable labels
Apparatus and method for information display of portable device
Vehicle grille
  Randomly Featured Patents
Refrigerator having controller for supplying water from a reservoir to either an ice maker or an outside dispenser
Remote amplifier for an optical transmission system and method of evaluating a faulty point
Eyeglass holder
Curable organopolysiloxane composition and mother mold for cast molding
Method of emulsifying cholesterol, cholesterol esters and triglyceride compounds
On-chip power supply interface with load-independent current demand
Snow thrower
Cross USB drive
Portable room divider apparatus
Casing seal means for a rotary piston engine